STLN vs TDOC
Starling Oncology, Inc. - Common Stock · Teladoc Health, Inc. Common Stock
Relative return (rebased to 100)
Key stats
| Metric | STLN | TDOC |
|---|---|---|
| Price | $6.17 | $6.50 |
| Market Cap | $628.82M | $1.18B |
| P/E | — | — |
| P/B | — | 0.90 |
| P/S | 1.25 | 0.47 |
| ROE | — | -15.3% |
| Net Margin | -12.1% | -7.9% |
| Gross Margin | — | 11.4% |
| Revenue Growth | 27.8% | -1.5% |
| Dividend Yield | — | — |
| EPS | -$0.59 | -$1.10 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.